{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:07:02Z","timestamp":1794539222316,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Key Research and Development Programme"},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020M672064"],"award-info":[{"award-number":["2020M672064"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010909","name":"National Science Foundation of China | Young Scientists Fund","doi-asserted-by":"publisher","award":["82001687"],"award-info":[{"award-number":["82001687"]}],"id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Postdoctoral Programme for Innovative Talents"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-022-00939-1","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T02:35:46Z","timestamp":1668134146000},"page":"1347-1360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Cholesterol accumulation on dendritic cells reverses chronic hepatitis B virus infection-induced dysfunction"],"prefix":"10.1038","volume":"19","author":[{"given":"Huajun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuju","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5106-1397","authenticated-orcid":false,"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"key":"939_CR1","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1001\/jama.2018.3795","volume":"319","author":"LSY Tang","year":"2018","unstructured":"Tang LSY, Covert E, Wilson E, Kottilil S. Chronic Hepatitis B infection: A review. JAMA. 2018;319:1802\u201313.","journal-title":"JAMA"},{"key":"939_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1055\/s-0037-1600522","volume":"37","author":"US Gill","year":"2017","unstructured":"Gill US, Bertoletti A. Clinical trial design for immune-based Therapy of Hepatitis B virus. Semin Liver Dis. 2017;37:85\u201394.","journal-title":"Semin Liver Dis"},{"key":"939_CR3","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.3748\/wjg.v25.i27.3527","volume":"25","author":"TY Li","year":"2019","unstructured":"Li TY, Yang Y, Zhou G, Tu ZK. Immune suppression in chronic hepatitis B infection associated liver disease: A review. World J Gastroenterol. 2019;25:3527\u201337.","journal-title":"World J Gastroenterol"},{"key":"939_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jaci.2009.11.019","volume":"125","author":"N Novak","year":"2010","unstructured":"Novak N, Koch S, Allam JP, Bieber T. Dendritic cells: bridging innate and adaptive immunity in atopic dermatitis. J Allergy Clin Immunol. 2010;125:50\u201359.","journal-title":"J Allergy Clin Immunol"},{"key":"939_CR5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/hep.30637","volume":"70","author":"A Yonejima","year":"2019","unstructured":"Yonejima A, Mizukoshi E, Tamai T, Nakagawa H, Kitahara M, Yamashita T, et al. Characteristics of impaired dendritic cell function in patients with Hepatitis B virus infection. Hepatology. 2019;70:25\u201339.","journal-title":"Hepatology"},{"key":"939_CR6","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/labinvest.2016.96","volume":"96","author":"M Li","year":"2016","unstructured":"Li M, Zhou ZH, Sun XH, Zhang X, Zhu XJ, Jin SG, et al. Hepatitis B core antigen upregulates B7-H1 on dendritic cells by activating the AKT\/ERK\/P38 pathway: a possible mechanism of hepatitis B virus persistence. Lab Invest. 2016;96:1156\u201364.","journal-title":"Lab Invest"},{"key":"939_CR7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3389\/fimmu.2020.00849","volume":"11","author":"P Fisicaro","year":"2020","unstructured":"Fisicaro P, Barili V, Rossi M, Montali I, Vecchi A, Acerbi G, et al. Pathogenetic mechanisms of T cell dysfunction in chronic HBV infection and related therapeutic approaches. Front Immunol. 2020;11:849.","journal-title":"Front Immunol"},{"key":"939_CR8","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.immuni.2017.11.021","volume":"47","author":"K Man","year":"2017","unstructured":"Man K, Gabriel SS, Liao Y, Gloury R, Preston S, Henstridge DC, et al. Transcription Factor IRF4 promotes CD8(+) T cell exhaustion and limits the development of memory-like T cells during chronic infection. Immunity. 2017;47:1129\u201341.","journal-title":"Immunity"},{"key":"939_CR9","doi-asserted-by":"publisher","first-page":"5334","DOI":"10.1093\/emboj\/17.18.5334","volume":"17","author":"C Montixi","year":"1998","unstructured":"Montixi C, Langlet C, Bernard AM, Thimonier J, Dubois C, Wurbel MA, et al. Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains. EMBO J. 1998;17:5334\u201348.","journal-title":"EMBO J"},{"key":"939_CR10","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.4049\/jimmunol.170.3.1329","volume":"170","author":"EM Hiltbold","year":"2003","unstructured":"Hiltbold EM, Poloso NJ, Roche PA. MHC class II-peptide complexes and APC lipid rafts accumulate at the immunological synapse. J Immunol. 2003;170:1329\u201338.","journal-title":"J Immunol"},{"key":"939_CR11","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1053\/j.gastro.2020.01.028","volume":"158","author":"WH Qin","year":"2020","unstructured":"Qin WH, Yang ZS, Li M, Chen Y, Zhao XF, Qin YY, et al. High serum levels of cholesterol increase antitumor functions of nature killer cells and reduce growth of liver tumors in mice. Gastroenterology. 2020;158:1713\u201327.","journal-title":"Gastroenterology"},{"key":"939_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","volume":"21","author":"J Luo","year":"2020","unstructured":"Luo J, Yang H, Song BL. Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2020;21:225\u201345.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"939_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22967-7","volume":"12","author":"NM Schmidt","year":"2021","unstructured":"Schmidt NM, Wing PAC, Diniz MO, Pallett LJ, Swadling L, Harris JM, et al. Targeting human Acyl-CoA:cholesterol acyltransferase as a dual viral and T cell metabolic checkpoint. Nat Commun. 2021;12:2814.","journal-title":"Nat Commun"},{"key":"939_CR14","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nature17412","volume":"531","author":"W Yang","year":"2016","unstructured":"Yang W, Bai Y, Xiong Y, Zhang J, Chen S, Zheng X, et al. Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism. Nature. 2016;531:651\u20135.","journal-title":"Nature"},{"key":"939_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1084\/jem.20151570","volume":"213","author":"LA O\u2019Neill","year":"2016","unstructured":"O\u2019Neill LA, Pearce EJ. Immunometabolism governs dendritic cell and macrophage function. J Exp Med. 2016;213:15\u201323.","journal-title":"J Exp Med"},{"key":"939_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.immuni.2015.08.023","volume":"43","author":"GD Norata","year":"2015","unstructured":"Norata GD, Caligiuri G, Chavakis T, Matarese G, Netea MG, Nicoletti A, et al. The cellular and molecular basis of translational immunometabolism. Immunity. 2015;43:421\u201334.","journal-title":"Immunity"},{"key":"939_CR17","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464:1357\u201361.","journal-title":"Nature"},{"key":"939_CR18","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nm1008","volume":"10","author":"H Bjorkbacka","year":"2004","unstructured":"Bjorkbacka H, Kunjathoor VV, Moore KJ, Koehn S, Ordija CM, Lee MA, et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med. 2004;10:416\u201321.","journal-title":"Nat Med"},{"key":"939_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/77842","volume":"1","author":"HA Anderson","year":"2000","unstructured":"Anderson HA, Hiltbold EM, Roche PA. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat Immunol. 2000;1:156\u201362.","journal-title":"Nat Immunol"},{"key":"939_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1365-3083.2006.01700.x","volume":"63","author":"E Eren","year":"2006","unstructured":"Eren E, Yates J, Cwynarski K, Preston S, Dong R, Germain C, et al. Location of major histocompatibility complex class II molecules in rafts on dendritic cells enhances the efficiency of T-cell activation and proliferation. Scand J Immunol. 2006;63:7\u201316.","journal-title":"Scand J Immunol"},{"key":"939_CR21","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.immuni.2016.11.008","volume":"45","author":"A Ito","year":"2016","unstructured":"Ito A, Hong C, Oka K, Salazar JV, Diehl C, Witztum JL, et al. Cholesterol accumulation in CD11c(+) immune cells is a causal and targetable factor in autoimmune disease. Immunity. 2016;45:1311\u201326.","journal-title":"Immunity"},{"key":"939_CR22","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.cmet.2017.04.005","volume":"25","author":"M Westerterp","year":"2017","unstructured":"Westerterp M, Gautier EL, Ganda A, Molusky MM, Wang W, Fotakis P, et al. Cholesterol accumulation in dendritic cells links the inflammasome to acquired immunity. Cell Metab. 2017;25:1294\u2013304.","journal-title":"Cell Metab"},{"key":"939_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05322-1","volume":"9","author":"F Bonacina","year":"2018","unstructured":"Bonacina F, Coe D, Wang G, Longhi MP, Baragetti A, Moregola A, et al. Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation. Nat Commun. 2018;9:3083.","journal-title":"Nat Commun"},{"key":"939_CR24","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1136\/gutjnl-2017-315588","volume":"68","author":"HJ Zhao","year":"2019","unstructured":"Zhao HJ, Han QJ, Wang G, Lin A, Xu DQ, Wang YQ, et al. Poly I:C-based rHBVvac therapeutic vaccine eliminates HBV via generation of HBV-specific CD8(+) effector memory T cells. Gut. 2019;68:2032\u201343.","journal-title":"Gut"},{"key":"939_CR25","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/hep.29239","volume":"66","author":"Y Bian","year":"2017","unstructured":"Bian Y, Zhang Z, Sun Z, Zhao J, Zhu D, Wang Y, et al. Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice. Hepatology. 2017;66:1067\u201382.","journal-title":"Hepatology"},{"key":"939_CR26","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.2147\/IJN.S317113","volume":"16","author":"H Zhao","year":"2021","unstructured":"Zhao H, Wang H, Hu Y, Xu D, Yin C, Han Q, et al. Chitosan nanovaccines as efficient carrier adjuvant system for IL-12 with enhanced protection against HBV. Int J Nanomed. 2021;16:4913\u201328.","journal-title":"Int J Nanomed"},{"key":"939_CR27","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1093\/eurheartj\/ehz310","volume":"41","author":"S Tsimikas","year":"2020","unstructured":"Tsimikas S, Gordts P, Nora C, Yeang C, Witztum JL. Statin therapy increases lipoprotein(a) levels. Eur Heart J. 2020;41:2275\u201384.","journal-title":"Eur Heart J"},{"key":"939_CR28","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1194\/jlr.M067488","volume":"57","author":"M Schonewille","year":"2016","unstructured":"Schonewille M, de Boer JF, Mele L, Wolters H, Bloks VW, Wolters JC, et al. Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice. J Lipid Res. 2016;57:1455\u201364.","journal-title":"J Lipid Res"},{"key":"939_CR29","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.stem.2018.12.013","volume":"24","author":"R van der Kant","year":"2019","unstructured":"van der Kant R, Langness VF, Herrera CM, Williams DA, Fong LK, Leestemaker Y, et al. Cholesterol metabolism is a druggable axis that independently regulates tau and amyloid-beta in iPSC-derived Alzheimer\u2019s disease neurons. Cell Stem Cell. 2019;24:363\u201375.","journal-title":"Cell Stem Cell"},{"key":"939_CR30","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.omtm.2020.03.017","volume":"17","author":"Y Gong","year":"2020","unstructured":"Gong Y, Klein Wolterink RGJ, Janssen I, Groot AJ, Bos GMJ, Germeraad WTV. Rosuvastatin enhances VSV-G lentiviral transduction of NK Cells via upregulation of the low-density lipoprotein receptor. Mol Ther Methods Clin Dev. 2020;17:634\u201346.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"939_CR31","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/ni.3200","volume":"16","author":"A Schlitzer","year":"2015","unstructured":"Schlitzer A, Sivakamasundari V, Chen J, Sumatoh HR, Schreuder J, Lum J, et al. Identification of cDC1- and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow. Nat Immunol. 2015;16:718\u201328.","journal-title":"Nat Immunol"},{"key":"939_CR32","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3389\/fimmu.2019.01014","volume":"10","author":"R Noubade","year":"2019","unstructured":"Noubade R, Majri-Morrison S, Tarbell KV. Beyond cDC1: Emerging roles of DC crosstalk in cancer immunity. Front Immunol. 2019;10:1014.","journal-title":"Front Immunol"},{"key":"939_CR33","doi-asserted-by":"publisher","first-page":"766534","DOI":"10.3389\/fimmu.2021.766534","volume":"12","author":"Y Du","year":"2021","unstructured":"Du Y, Broering R, Li X, Zhang X, Liu J, Yang D, et al. In vivo mouse models for hepatitis b virus infection and their application. Front Immunol. 2021;12:766534.","journal-title":"Front Immunol"},{"key":"939_CR34","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s12035-020-02232-6","volume":"58","author":"L Dai","year":"2021","unstructured":"Dai L, Zou L, Meng L, Qiang G, Yan M, Zhang Z. Cholesterol metabolism in neurodegenerative diseases: molecular mechanisms and therapeutic targets. Mol Neurobiol. 2021;58:2183\u2013201.","journal-title":"Mol Neurobiol"},{"key":"939_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","volume":"30","author":"X Ma","year":"2019","unstructured":"Ma X, Bi E, Lu Y, Su P, Huang C, Liu L, et al. Cholesterol induces CD8(+) T cell exhaustion in the tumor microenvironment. Cell Metab. 2019;30:143\u201356 e145.","journal-title":"Cell Metab"},{"key":"939_CR36","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nri3793","volume":"15","author":"AR Tall","year":"2015","unstructured":"Tall AR, Yvan-Charvet L. Cholesterol, inflammation and innate immunity. Nat Rev Immunol. 2015;15:104\u201316.","journal-title":"Nat Rev Immunol"},{"key":"939_CR37","doi-asserted-by":"publisher","first-page":"7377","DOI":"10.4049\/jimmunol.172.12.7377","volume":"172","author":"M Matsumoto","year":"2004","unstructured":"Matsumoto M, Einhaus D, Gold ES, Aderem A. Simvastatin augments lipopolysaccharide-induced proinflammatory responses in macrophages by differential regulation of the c-Fos and c-Jun transcription factors. J Immunol. 2004;172:7377\u201384.","journal-title":"J Immunol"},{"key":"939_CR38","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.immuni.2018.08.021","volume":"49","author":"C Guo","year":"2018","unstructured":"Guo C, Chi Z, Jiang D, Xu T, Yu W, Wang Z, et al. Cholesterol homeostatic regulator SCAP-SREBP2 integrates NLRP3 Inflammasome activation and cholesterol biosynthetic signaling in macrophages. Immunity. 2018;49:842\u201356.","journal-title":"Immunity"},{"key":"939_CR39","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.3389\/fimmu.2018.02137","volume":"9","author":"JAF Braga Filho","year":"2018","unstructured":"Braga Filho JAF, Abreu AG, Rios CEP, Trovao LO, Silva DLF, Cysne DN, et al. Prophylactic treatment with simvastatin modulates the immune response and increases animal survival following lethal sepsis infection. Front Immunol. 2018;9:2137.","journal-title":"Front Immunol"},{"key":"939_CR40","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.cell.2018.08.070","volume":"175","author":"Y Xia","year":"2018","unstructured":"Xia Y, Xie Y, Yu Z, Xiao H, Jiang G, Zhou X, et al. The mevalonate pathway is a druggable target for vaccine adjuvant discovery. Cell. 2018;175:1059\u201373.","journal-title":"Cell"},{"key":"939_CR41","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/hep.29172","volume":"66","author":"FM Chang","year":"2017","unstructured":"Chang FM, Wang YP, Lang HC, Tsai CF, Hou MC, Lee FY, et al. Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study. Hepatology. 2017;66:896\u2013907.","journal-title":"Hepatology"},{"key":"939_CR42","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1002\/hep.30973","volume":"71","author":"MJ Goh","year":"2020","unstructured":"Goh MJ, Sinn DH, Kim S, Woo SY, Cho H, Kang W, et al. Statin use and the risk of hepatocellular carcinoma in patients with chronic Hepatitis B. Hepatology. 2020;71:2023\u201332.","journal-title":"Hepatology"},{"key":"939_CR43","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1053\/j.gastro.2010.08.055","volume":"140","author":"GA Rao","year":"2011","unstructured":"Rao GA, Pandya PK. Statin therapy improves sustained virologic response among diabetic patients with chronic hepatitis C. Gastroenterology. 2011;140:144\u201352.","journal-title":"Gastroenterology"},{"key":"939_CR44","doi-asserted-by":"publisher","first-page":"101054","DOI":"10.1016\/j.plipres.2020.101054","volume":"79","author":"AM Gorabi","year":"2020","unstructured":"Gorabi AM, Kiaie N, Bianconi V, Jamialahmadi T, Al-Rasadi K, Johnston TP, et al. Antiviral effects of statins. Prog Lipid Res. 2020;79:101054.","journal-title":"Prog Lipid Res"},{"key":"939_CR45","doi-asserted-by":"publisher","first-page":"e00660","DOI":"10.1128\/mBio.00660-18","volume":"9","author":"P Shrivastava-Ranjan","year":"2018","unstructured":"Shrivastava-Ranjan P, Flint M, Bergeron \u00c9, McElroy AK, Chatterjee P, Albari\u00f1o CG, et al. Statins suppress Ebola virus infectivity by interfering with glycoprotein processing. mBio. 2018;9:e00660\u201318.","journal-title":"mBio"},{"key":"939_CR46","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/ehjcvp\/pvaa050","volume":"6","author":"RG Abdel-Latif","year":"2020","unstructured":"Abdel-Latif RG, Mohammed S, Elgendy IY. Statin therapy and SAR-COV-2: an available and potential therapy? Eur Heart J Cardiovasc Pharmacother. 2020;6:333\u20134.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"939_CR47","doi-asserted-by":"publisher","first-page":"7672","DOI":"10.4049\/jimmunol.0902874","volume":"183","author":"D Rai","year":"2009","unstructured":"Rai D, Pham NL, Harty JT, Badovinac VP. Tracking the total CD8 T cell response to infection reveals substantial discordance in magnitude and kinetics between inbred and outbred hosts. J Immunol. 2009;183:7672\u201381.","journal-title":"J Immunol"},{"key":"939_CR48","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.tim.2016.05.006","volume":"24","author":"C Shih","year":"2016","unstructured":"Shih C, Chou SF, Yang CC, Huang JY, Choijilsuren G, Jhou RS. Control and eradication strategies of Hepatitis B virus. Trends Microbiol. 2016;24:739\u201349.","journal-title":"Trends Microbiol"},{"key":"939_CR49","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry EJ. T cell exhaustion. Nat Immunol. 2011;12:492\u20139.","journal-title":"Nat Immunol"},{"key":"939_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.coi.2017.07.016","volume":"48","author":"MA Cox","year":"2017","unstructured":"Cox MA, Nechanitzky R, Mak TW. Check point inhibitors as therapies for infectious diseases. Curr Opin Immunol. 2017;48:61\u20137.","journal-title":"Curr Opin Immunol"},{"key":"939_CR51","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","volume":"20","author":"BC Miller","year":"2019","unstructured":"Miller BC, Sen DR, Al Abosy R, Bi K, Virkud YV, LaFleur MW, et al. Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade. Nat Immunol. 2019;20:326\u201336.","journal-title":"Nat Immunol"},{"key":"939_CR52","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/cmi.2015.64","volume":"13","author":"X Wang","year":"2016","unstructured":"Wang X, Dong A, Xiao J, Zhou X, Mi H, Xu H, et al. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice. Cell Mol Immunol. 2016;13:850\u201361.","journal-title":"Cell Mol Immunol"},{"key":"939_CR53","doi-asserted-by":"publisher","first-page":"154","DOI":"10.7150\/ijbs.62424","volume":"18","author":"H Zhao","year":"2022","unstructured":"Zhao H, Han Q, Yang A, Wang Y, Wang G, Lin A, et al. CpG-C ODN M362 as an immunoadjuvant for HBV therapeutic vaccine reverses the systemic tolerance against HBV. Int J Biol Sci. 2022;18:154\u201365.","journal-title":"Int J Biol Sci"},{"key":"939_CR54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","volume":"24","author":"A Wahlstr\u00f6m","year":"2016","unstructured":"Wahlstr\u00f6m A, Sayin SI, Marschall HU, B\u00e4ckhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24:41\u201350.","journal-title":"Cell Metab"},{"key":"939_CR55","doi-asserted-by":"publisher","first-page":"109726","DOI":"10.1016\/j.celrep.2021.109726","volume":"36","author":"J Hu","year":"2021","unstructured":"Hu J, Wang C, Huang X, Yi S, Pan S, Zhang Y, et al. Gut microbiota-mediated secondary bile acids regulate dendritic cells to attenuate autoimmune uveitis through TGR5 signaling. Cell Rep. 2021;36:109726.","journal-title":"Cell Rep"},{"key":"939_CR56","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.3389\/fimmu.2019.03127","volume":"10","author":"Z Meng","year":"2019","unstructured":"Meng Z, Chen Y, Lu M. Advances in targeting the innate and adaptive immune systems to cure chronic Hepatitis B Virus infection. Front Immunol. 2019;10:3127.","journal-title":"Front Immunol"},{"key":"939_CR57","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1001\/jama.2016.16557","volume":"316","author":"PD Thompson","year":"2016","unstructured":"Thompson PD. What to believe and do about statin-associated adverse effects. JAMA. 2016;316:1969\u201370.","journal-title":"JAMA"},{"key":"939_CR58","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.autrev.2004.08.037","volume":"4","author":"VS Gurevich","year":"2005","unstructured":"Gurevich VS, Shovman O, Slutzky L, Meroni PL, Shoenfeld Y. Statins and autoimmune diseases. Autoimmun Rev. 2005;4:123\u20139.","journal-title":"Autoimmun Rev"},{"key":"939_CR59","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1016\/S0140-6736(04)16423-4","volume":"363","author":"B No\u00ebl","year":"2004","unstructured":"No\u00ebl B. Autoimmune disease and other potential side-effects of statins. Lancet. 2004;363:2000.","journal-title":"Lancet"},{"key":"939_CR60","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/S0140-6736(04)15739-5","volume":"363","author":"B Moosmann","year":"2004","unstructured":"Moosmann B, Behl C. Selenoprotein synthesis and side-effects of statins. Lancet. 2004;363:892\u20134.","journal-title":"Lancet"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-022-00939-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-022-00939-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-022-00939-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T15:40:39Z","timestamp":1678549239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-022-00939-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":60,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["939"],"URL":"https:\/\/doi.org\/10.1038\/s41423-022-00939-1","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]},"assertion":[{"value":"6 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}